Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1975 1
1993 1
1996 3
1999 1
2000 1
2004 1
2008 1
2009 4
2010 2
2011 3
2012 3
2013 5
2014 11
2015 5
2016 7
2017 6
2018 10
2019 5
2020 6
2021 6
2022 5
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP; Secukinumab in Crohn's Disease Study Group. Hueber W, et al. Among authors: karczewski m. Gut. 2012 Dec;61(12):1693-700. doi: 10.1136/gutjnl-2011-301668. Epub 2012 May 17. Gut. 2012. PMID: 22595313 Free PMC article. Clinical Trial.
Neurologic complications in kidney transplant recipients.
Piotrowski PC, Lutkowska A, Tsibulski A, Karczewski M, Jagodziński PP. Piotrowski PC, et al. Among authors: karczewski m. Folia Neuropathol. 2017;55(2):86-109. doi: 10.5114/fn.2017.68577. Folia Neuropathol. 2017. PMID: 28677367 Free article. Review.
Microwave-assisted cobinamide synthesis.
O Proinsias K, Karczewski M, Zieleniewska A, Gryko D. O Proinsias K, et al. Among authors: karczewski m. J Org Chem. 2014 Aug 15;79(16):7752-7. doi: 10.1021/jo501364b. Epub 2014 Jul 31. J Org Chem. 2014. PMID: 25058239
Fatigue in children with neurologic impairments.
Nutini M, Karczewski M, Capoor J. Nutini M, et al. Among authors: karczewski m. Phys Med Rehabil Clin N Am. 2009 May;20(2):339-46. doi: 10.1016/j.pmr.2008.12.004. Phys Med Rehabil Clin N Am. 2009. PMID: 19389615 Review.
Impaired Expression of Humanin during Adrenocortical Carcinoma.
Blatkiewicz M, Szyszka M, Olechnowicz A, Kamiński K, Jopek K, Komarowska H, Tyczewska M, Klimont A, Wierzbicki T, Karczewski M, Ruchała M, Rucinski M. Blatkiewicz M, et al. Among authors: karczewski m. Int J Mol Sci. 2024 Jan 15;25(2):1038. doi: 10.3390/ijms25021038. Int J Mol Sci. 2024. PMID: 38256114 Free PMC article.
meso-Modified Cobalamins: Synthesis, Structure, and Properties.
Wierzba AJ, Wincenciuk A, Karczewski M, Vullev VI, Gryko D. Wierzba AJ, et al. Among authors: karczewski m. Chemistry. 2018 Jul 20;24(41):10344-10356. doi: 10.1002/chem.201801807. Epub 2018 Jun 27. Chemistry. 2018. PMID: 29719071
98 results